Market Overview

Patient Journey Mapping Helped a Leading New Cancer Drugs Manufacturer Form a Company-Wide Agreement on Key Issues and Unmet Needs | Quantzig


Quantzig, a pure-play analytics solutions provider, has announced the
completion of their latest patient
journey mapping on the new cancer drugs industry
. The client in the
new cancer drugs market wanted to understand the regional unmet needs of
the US and European patient population in the advanced stage of the
disease and gain prominence in the therapeutic area.

This press release features multimedia. View the full release here:

Patient journey mapping helped a leading new cancer drugs manufacturer form a company-wide agreement ...

Patient journey mapping helped a leading new cancer drugs manufacturer form a company-wide agreement on key issues and unmet needs. (Graphic: Business Wire)

According to the patient journey mapping experts at Quantzig,
" Patient journey mapping allows providers to improve outcomes for
the challenged oncology patient population across the globe."

The new cancer drugs developers are highly focused on improving cancer
treatments. In cancer, early tumor detection with non-invasive imaging
such as MRI, CT, and PET scans are increasingly promising for
discriminating between aggressive and indolent tumors. However, these
are expensive interventions that also increase an individual's exposure
to radiation and can result in a high false-positive rate. New
innovations will possibly add further to the challenges and complexities
of drug development to meet the increased need for precision medicine.

a Solution Demo
to see how Quantzig's solutions can help you.

The patient journey mapping solution helped the new cancer drugs
manufacturer to prioritize the list of unmet needs of the patient
population and recognize opportunities for promoters to share their
resources with each other. Also, this nurtured a company-wide agreement
on key issues and unmet needs.

This patient journey mapping solution provided
benefits that helped the client to:

  • Classify the priority areas to increase awareness of options, improve
    patient quality of life, including new treatments and clinical trials
  • Empower the patients to be active in their care plans
  • To know more about the benefits of patient journey mapping
    to an expert

This patient journey mapping solution offered
predictive insights on:

  • Establishing as a trusted leader in oncology research
  • Reinforcing the promise to improve outcomes for the challenged
    oncology patient population
  • To gain relevant insights and understand the scope of our research, request
    a proposal

View the complete patient journey mapping summary here:

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US,
UK, Canada, China, and India. For more than 15 years, we have assisted
our clients across the globe with end-to-end data modeling capabilities
to leverage analytics for prudent decision making. Today, our firm
consists of 120+ clients, including 45 Fortune 500 companies. For more
information on all of Quantzig's services and the solutions they have
provided to Fortune 500 clients across all industries, please contact us.

View Comments and Join the Discussion!